Overview
Overview
A Prospective, Observational, Multi-Center Study to Evaluate Clinical, Laboratory, Immunologic and Viral Markers of Disease Progression in Recently HIV-Infected Volunteers from IAVI Affiliated HIV Vaccine Clinical Trials
Sponser
Sponser
Principal Investigator
Principle Instigator
Dr. Gaudensia Mutua
Abstract
Abstract
Primary Objective: To assess laboratory and clinical markers of HIV disease progression including CD4 T-cell counts and viral load trajectories over a defined time, and time to ART initiation in HIV vaccine trial participants who acquire HIV infection.
